ISSN:
1573-2584
Source:
Springer Online Journal Archives 1860-2000
Topics:
Medicine
Notes:
Abstract Disturbances in purine metabolism with hyperuricaemia and/or hyperuricosuria are a risk factor in uric acid and Ca oxalate stone formation. By way of a competitive xanthine oxidase inhibition, the formation of uric acid is reduced by allopurinol. In investigations on two groups of patients, MiluritR could be demonstrated to decrease the uric acid levels in serum and urine. No differences could be seen in the dosages of 3×100 mg or 1×300 mg Milurit. Therefore, in stone recurrence prevention, the administration of Milurit 300R is recommended.
Type of Medium:
Electronic Resource
URL:
http://dx.doi.org/10.1007/BF02085441